Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer.
Biologics., 6:395-407 (2012)
Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy.
J. Urol., Jan;189(1):43-7 (2013)
The impact of dose-escalated radiotherapy plus androgen deprivation for prostate cancer using 2 linked nomograms.
Cancer., Oct (2012)
Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses.
Can J Urol., Oct;19(5):6417-22 (2012)
Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors.
Urology., Aug;80(2):286-91 (2012)
Thermal ablation of the small renal mass: Case selection using the R.E.N.A.L-Nephrometry Score.
Urol. Oncol., Apr (2012)
Perioperative outcomes of robotic and open partial nephrectomy for moderately and highly complex renal lesions.
J. Urol., Jun;187(6):2000-4 (2012)
Partial nephrectomy for renal masses â‰¥ 7 cm: technical, oncological and functional outcomes.
BJU Int., May;109(10):1450-6 (2012)
A pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growth.
Cancer Res., Feb;72(3):736-46 (2012)
Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection.
Cancer Epidemiol. Biomarkers Prev., Jan;21(1):53-60 (2012)
Molecular imaging of the small renal mass.
Urol. Oncol., 29(6):589-92 (2011 Nov-Dec)
Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass.
Urology., Nov;78(5):1089-94 (2011)
PSA Doubling Time Predicts for the Development of Distant Metastases for Patients Who Fail 3DCRT Or IMRT Using the Phoenix Definition.
Pract Radiat Oncol., 1(4):235-242 (2011)
Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer.
Radiother Oncol., Dec;101(3):508-12 (2011)
Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis.
Cancer., Feb;118(4):997-1006 (2012)
Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer.
Int. J. Radiat. Oncol. Biol. Phys., Apr;82(5):1949-56 (2012)
Delayed proximal ureteric stricture formation after complex partial nephrectomy.
BJU Int., Feb;109(4):539-43 (2012)
Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy.
Eur. Urol., Oct;60(4):724-30 (2011)
Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score.
Eur. Urol., Aug;60(2):241-8 (2011)
Routine adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the adrenal gland is radiographically normal.
J. Urol., Apr;185(4):1198-203 (2011)
Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors.
Urology., Apr;77(4):781-5 (2011)
Evaluation and management of the renal mass.
Med. Clin. North Am., Jan;95(1):179-89 (2011)
Percutaneous vs surgical cryoablation of the small renal mass: is efficacy compromised?
BJU Int., May;107(9):1376-80 (2011)
Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer.
Int. J. Radiat. Oncol. Biol. Phys., Jun;80(2):437-44 (2011)
Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val.
BJU Int., Feb;107(3):466-70 (2011)
Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy.
Urology., Jan;77(1):160-5 (2011)
Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy.
BJU Int., Jan;107(1):58-62 (2011)
Taspase1 functions as a non-oncogene addiction protease that coordinates cancer cell proliferation and apoptosis.
Cancer Res., Jul;70(13):5358-67 (2010)
Robot-assisted partial nephrectomy: a large single-institutional experience.
Urology., Jun;75(6):1328-34 (2010)
Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy.
BJU Int., Jul;106(2):218-23 (2010)
An intraoperative real-time sleeved seed technique for permanent prostate brachytherapy.
Brachytherapy., 9(2):126-30 (2010 Apr-Jun)
J. Urol., Nov;182(5):2120-1; discussion 2122 (2009)
Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk screening population.
BJU Int., Feb;105(3):334-7 (2010)
Design, syntheses, and evaluation of Taspase1 inhibitors.
Bioorg. Med. Chem. Lett., Sep;19(17):5086-90 (2009)
Optimal management of localized renal cell carcinoma: surgery, ablation, or active surveillance.
J Natl Compr Canc Netw., Jun;7(6):635-42; quiz 643 (2009)
Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance.
Cancer., Jul;115(13):2844-52 (2009)
Marine fish food in the United States and methylmercury risk.
Int J Environ Health Res., Apr;19(2):109-24 (2009)
Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men.
Cancer Prev Res (Phila)., Mar;2(3):244-50 (2009)
The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damage.
Proc. Natl. Acad. Sci. U.S.A., Jan;106(4):1093-8 (2009)
O doctor, where art thou? Why fewer students pursue internal medicine.
Virtual Mentor., 11(5):378-82 (2009)
Predicting growth of solid renal masses under active surveillance.
Urol. Oncol., 26(5):555-9 (2008 Sep-Oct)
Does treatment duration affect outcome after radiotherapy for prostate cancer?
Int. J. Radiat. Oncol. Biol. Phys., Dec;72(5):1402-7 (2008)
Residual prostate cancer after radiotherapy: a study of radical cystoprostatectomy specimens.
Urology., Sep;72(3):654-8 (2008)
Delayed intervention of sporadic renal masses undergoing active surveillance.
Cancer., Mar;112(5):1051-7 (2008)
Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer?
Urology., May;71(5):938-41 (2008)
A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant.
Int. J. Radiat. Oncol. Biol. Phys., Jun;71(2):338-45 (2008)
Intensity Modulated Radiation Therapy Reduces Gastrointestinal Toxicity in Patients Treated with Androgen Deprivation Therapy for Prostate Cancer.
Int. J. Radiat. Oncol. Biol. Phys., Nov;69(3):S10 (2007)
Prostate cancer risk assessment program: a 10-year update of cancer detection.
J. Urol., Nov;178(5):1920-4; discussion 1924 (2007)
Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate.
Cancer., May;109(10):2011-5 (2007)
Enhancing renal masses with zero net growth during active surveillance.
J. Urol., Mar;177(3):849-53; discussion 853-4 (2007)
Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression.
Genes Dev., Sep;20(17):2397-409 (2006)
The natural history of observed enhancing renal masses: meta-analysis and review of the world literature.
J. Urol., Feb;175(2):425-31 (2006)
Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.
Cancer Res., Apr;65(7):2755-60 (2005)
Treatment of adrenocortical carcinoma: contemporary outcomes.
Curr Urol Rep., Feb;5(1):65-72 (2004)
Inhibition of transcription elongation by the VHL tumor suppressor protein.
Science., Sep;269(5229):1402-6 (1995)
Varicocele in the rat: a new experimental model. Effect on histology, ultrastructure and temperature of the testis and the epididymis.
Urol. Res., 19(5):319-22 (1991)
Effects of cimetidine, progesterone, cannitracin and tolazoline on the weight and DNA content of the testosterone-induced hyperplastic prostate of the rat.
Urol. Res., 16(5):363-6 (1988)